Rituxan Hycela 50242-0109

Generic: Rituximab And Hyaluronidase

Product NDC

50242-0109

Manufacturer: Genentech, Inc.
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: June 22, 2017
Listing Expires: December 31, 2026
Application: BLA761064

Need to source Rituxan Hycela? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Hyaluronidase (human Recombinant)	2000 U/mL
Rituximab	120 mg/mL

Drug Class

CD20-directed Cytolytic Antibody [EPC]Endoglycosidase [EPC]CD20-directed Antibody Interactions [MoA]

Packaging Options(1)

50242-0109-01

1 VIAL, SINGLE-DOSE in 1 CARTON (50242-109-01) / 13.4 mL in 1 VIAL, SINGLE-DOSE

View →